Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

Cardio IQ Direct LDL

Also listed as
Cardio IQ® Direct LDL, bad cholesterol, ldl cholesterol, low density lipoprotein, ldl-c, Cardio IQ® Direct LDL
LOINC codes
13457-7, 2085-9, 2093-3, 2571-8, 33248-6, 43396-1, 64234-8, 79423-0, 8480-6, 95547-6, 95548-4, 95549-2, 9830-1
Tests that measure Cardio IQ Direct LDL
Quest Diagnostics 1

Ranges

Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ

Quest Diagnostics, Cardio IQ® ASCVD Risk Panel with Score 92052

Total CholesterolMale (mg/dL)Female (mg/dL)
<20 Years<170<170
≥20 Years<200<200
HDL Cholesterol
<20 Years>45>45
≥20 Years≥40≥50
Triglycerides
≤9 Years<75<75
10-19 Years<90<90
≥20 Years<150<150
LDL-Cholesterol (Calc)
<20 Years<110<110
≥20 Years<100<100
Cholesterol/HDL Ratio (Calc)<5.0<5.0
Non-HDL Cholesterol
<20 Years<120<120
≥20 Years<130<130
<130, ASCVD Risk ScoresSee Laboratory Report

Quest Diagnostics test catalog, 92052

Tests

Check the catalog code, specimen, method and preparation for every test that measures Cardio IQ Direct LDL. Select up to five tests to compare them side by side.

Quest Diagnostics 1 test

Panels that include this biomarker

  • Cardio IQ® ASCVD Risk Panel with Score 92052

    9 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Enzymatic • Spectrophotometry (SP)
    Preparation
    If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
    Collection
    For risk calculations to be performed, the following patient specific information have to be provided at time of order: Age: Years Gender: M (for male) or F (for female) Race-African American: Y (for yes) or N (for no) Systolic Blood Pressure: mmHg Treatment for High Blood Pressure: Y (for yes) or N (for no) Diabetes Status: Y (for yes) or N (for no) Smoking Status: Y (for Yes) or N (for no)
    Quest Diagnostics catalog page

0 of 5 tests selected

Pick one more

Sources

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.